FDA Inspection 1305848 - Richard A. Lafayette, M.D. - March 04, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Richard A. Lafayette, M.D., with an inspection on March 4, 2026, issued by the San Francisco District Office, covering human drugs.

Company: Richard A. Lafayette, M.D.
Inspection Date: March 4, 2026
Product Type: Human Drugs
Office: San Francisco District Office

Open in Dashboard

ID · 83fae200-15ca-4542-ab37-f4da145499e7

Violation Codes1

21 CFR 312.60

Full citation text and observation details available on the Dashboard.